As filed with the Securities and Exchange Commission on May 19, 2015
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
Filed by the Registrant [X]
Filed by a Party other than the Registrant [ ]
Check the appropriate box:
[ ] | Preliminary Proxy Statement |
[ ] | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) |
[ ] | Definitive Proxy Statement |
[X] | Definitive Additional Materials |
[ ] | Soliciting Material under Rule 14a-12 |
ETFIS SERIES TRUST I
(Name of Registrant as Specified In Its Charter)
Not Applicable
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
[X] | No fee required |
[ ] | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11 |
(1) | Title of each class of securities to which transaction applies: | |
(2) | Aggregate number of securities to which transaction applies: | |
(3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11(Set forth the amount on which the filing fee is calculated and state how it was determined): | |
(4) | Proposed maximum aggregate value of transaction: | |
(5) | Total fee paid: | |
[ ] | Fee paid previously with preliminary materials. |
[ ] | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
(1) | Amount Previously Paid: | |
(2) | Form, Schedule or Registration Statement No.: | |
(3) | Filing Party: | |
(4) | Date Filed: |
Alliance Advisors | Shareholder Services Department |
May 20, 2015
URGENT
Re: Your Investment WithBioshares Biotechnology Products Fund (BBP)
A Series of ETF Series Trust I
Dear Shareholder,
We have attempted to contact you regarding an important matter pertaining to your investment in Bioshares Biotechnology Products Fund (BBP)
Bioshares Biotechnology Products Fund (BBP) was scheduled to hold their Special Meeting on May 15th, 2015. This meeting has beenadjourneduntil June 12th, 2015.
BBP is asking that you please take the time to vote on the following two proposals to avoid additional solicitation costs.
Proposal 1
To approve, with respect to BBP, a new Investment Advisory Agreement to be entered into by and between ETFis Series Trust I (The “Trust”) and ETFis Capital LLC (The “Adviser”)
Proposal 3
To Approve, with respect to the fund, a proposed new Investment Sub-Advisory Agreement to be entered into by and among the Trust, the Adviser and LifeSci IndexPartners, LLC
Please contact me immediately at855-723-7821, between the hours of 9:00 am and 10:00 pm Eastern time, Monday through Friday, This matter is very important, but will take only a moment of your time. Alliance Advisors has been engaged by BBP to contact you for your vote.
No personal information is required when calling.
Thank you in advance for your assistance with this matter.
Sincerely,
Gina Balderas
Manager
Shareholder Services
Alliance Advisors 200 Broadacres Drive Bloomfield NJ 07003
Alliance Advisors | Shareholder Services Department |
May 20, 2015
URGENT
Re: Your Investment WithBioshares Biotechnology Clinical Trials Fund (BBC)
A Series of ETF Series Trust I
Dear Shareholder,
We have attempted to contact you regarding an important matter pertaining to your investment in Bioshares Biotechnology Clinical Trials Fund (BBC)
Bioshares Biotechnology Clinical Trials Fund (BBC) was scheduled to hold their Special Meeting on May 15, 2015. This meeting has beenadjourneduntil June 12, 2015.
BBC is asking that you please take the time to vote on the following two proposals to avoid additional solicitation costs.
Proposal 1
To approve, with respect to BBC (the “Fund”), a new Investment Advisory Agreement to be entered into by and between ETFis Series Trust I (the “Trust”) and ETFis Capital LLC (The “Adviser”)
Proposal 3
To approve, with respect to the Fund, a proposed new Investment Sub-Advisory Agreement to be entered into by and among the Trust, the Adviser and LifeSci Index Partners, LLC.
Please contact me immediately at855-723-7821between the hours of 9:00 am and
10:00 pm. Eastern Time, Monday through Friday. This matter is very important, but will take only a moment of your time. Alliance Advisors has been engaged by BBC to contact you for your vote.
No personal information is required when calling.
Thank you in advance for your assistance with this matter.
Sincerely,
Gina Balderas
Manager
Shareholder Services
Alliance Advisors 200 Broadacres Drive Bloomfield NJ 07003